Rubus Sanctus (Wild Blackberry) Root Extract as a Dietary Supplement for Graves' Disease
NCT07164079 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42
Last updated 2025-09-09
Summary
The aim of this single-blind, randomized, experimental study was to investigate the effect of Rubus sanctus root extract, which has antioxidant properties, added to the routine diet of patients with Graves' disease on the prognosis of the disease.
The study sample included patients who presented to the Endocrinology and Metabolic Diseases Outpatient Clinic of Muğla Sıtkı Koçman University Training and Research Hospital and were diagnosed with Graves' disease or developed a relapse after necessary examinations. Cohen's standardized effect size was used. Accordingly, the required sample size for the study was determined to be 42, using an alpha value of 0.05, an effect size of 0.80, and a theoretical power of 80%. The study planned to include a minimum of 42 participants: 21 intervention participants and 21 controls.
Patients assigned to the control group were asked to continue their routine diet, adhere to any necessary pharmacological treatments, and consume a placebo tea for the planned 8-week intervention period. Routine monthly examinations will be collected, and anthropometric measurements will be repeated at the end of 8 weeks.
Patients assigned to the experimental group will be asked to continue their routine diet for 8 weeks, comply with any required pharmacological treatments, and consume Rubus sanctus root extract, produced by aqueous extraction and lyophilization, with active ingredient (phenolic compound) determined by LC-MS-MS, and prepared as a tea in 5-g packets. Anthropometric measurements will be repeated at the end of 8 weeks.
H0: Rubus sanctus root extract supplemented to the diet has no effect on Graves' disease.
H1: Rubus sanctus root extract supplemented to the diet has an effect on Graves' disease.
Conditions
- Graves Disease (Basedow's Disease)
Interventions
- DIETARY_SUPPLEMENT
-
blackberry root
Patients in the intervention group will receive a Rubus Sanctus root extract, which they will consume with breakfast for 8 weeks. The tea will be packaged as 5 grams of Rubus Sanctus root and steeped in 200 ml of water at 80°C for 5 minutes. Participants in the intervention group will receive the Rubus Sanctus root tea along with the necessary equipment (a 200 ml beaker and thermometer). Measurements of TSH, T4, T3, anti-TPO, anti-TG, TSH receptor antibodies, liver function tests, thyroid parenchymal echogenicity, and thyroid volume will be taken at the Endocrinology and Metabolic Diseases Clinic of Muğla Training and Research Hospital before and after the study.
- DIETARY_SUPPLEMENT
-
black tea
Patients with Graves' disease assigned to the control group will be asked to consume black tea (Camellia sinensis) with their breakfast for 8 weeks. Black tea is a product consumed almost daily in Turkish society. Black tea will be prepared in 5-g doses and steeped in 200 ml of water at 80°C for 5 minutes. Participants in the control group will be provided with black tea bags along with the necessary equipment (a 200 ml beaker and thermometer). TSH, T4, T3, anti-TPO, anti-TG, TSH receptor antibody, liver function tests, thyroid parenchymal echogenicity, and thyroid volume will be obtained before and after the study at the Endocrinology and Metabolic Diseases Clinic of Muğla Training and Research Hospital.
Sponsors & Collaborators
-
Betul Uner
lead OTHER
Principal Investigators
-
Betül Üner Yılmaz, Lecturer · https://www.mu.edu.tr/tr/personel/betuluner
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-12-12
- Primary Completion
- 2026-03-31
- Completion
- 2026-06-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Effect of Dill in Thyroiditis and Nodular Goiter Patients
NCT04482907 ·Status: COMPLETED ·Phase: NA
-
Effect of Photobiomodulation Therapy in Patients With Hashimoto's Thyroiditis
NCT06735040 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
NCT06727604 ·Status: RECRUITING ·Phase: PHASE2
-
Effects of Low-Level Laser Therapy on Oxidative Stress Levels
NCT04754607 ·Status: COMPLETED ·Phase: NA
-
Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease
NCT00946296 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Lugol's Solution in the Patients With Graves' Disease
NCT00432146 ·Status: COMPLETED
-
Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease
NCT02376088 ·Status: COMPLETED
-
Evaluation of Oxidative Stress and Effect of Levothyroxine Treatment on Oxidative Stress in Hashimoto Disease
NCT01102205 ·Status: COMPLETED
-
Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease
NCT07129642 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions
NCT01204359 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Evaluate the Safety and Effect of CFZ533 on Patients With Graves' Disease
NCT02713256 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Carum Carvi on Thyroid Hormones and TSH Level
NCT01471288 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease
NCT07261345 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
The Frequency of Thyroid Diseases in Women With Breast Cancer
NCT04406779 ·Status: COMPLETED
-
A Prospective Evaluation of Microwave Ablation (MWA) in the Treatment of Relapsed Graves' Disease
NCT06506149 ·Status: RECRUITING ·Phase: NA
-
In Vivo CAR-T for Refractory Graves' Disease
NCT07333677 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients
NCT02654041 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients
NCT01560299 ·Status: COMPLETED ·Phase: NA
-
The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma
NCT01707056 ·Status: WITHDRAWN ·Phase: NA
-
Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis
NCT05118542 ·Status: COMPLETED ·Phase: PHASE3
-
Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
NCT01295333 ·Status: COMPLETED ·Phase: PHASE3
-
Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation
NCT06426758 ·Status: NOT_YET_RECRUITING
-
Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism
NCT01611896 ·Status: COMPLETED ·Phase: NA
-
Incidence of Graves' Disease After COVID-19 Vaccination
NCT07213141 ·Status: ACTIVE_NOT_RECRUITING
-
K1-70 - A Study in Subjects With Graves' Disease
NCT02904330 ·Status: COMPLETED ·Phase: PHASE1